Floatz logo

Therapeutic Asset Ratings

124 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Capivasertib
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP2B (58)
Crizotinib
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP2B (58)
FLUOROURACILUM
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (58)
Gdc-0449
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP2B (58)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP2B (58)
Tak-228
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP2B (58)
Talzenna
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (58)
Trastuzumab Deruxtecan
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (58)
VEMURAFENIB
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP2B (58)
MEGESTROL ACETATE IMPURITY B
Advanced Malignant Solid Neoplasm
Alliance for Clinical Trials in OncologyP3B (57)
azd6244
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (57)
Binimetinib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (57)
Copanlisib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (57)
Dasatinib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (57)
Fexagratinib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (57)
Hydroxychloroquine
Advanced Malignant Solid Neoplasm
Northwestern UniversityP2B (57)
PI3K/MTOR INHIBITOR LY3023414
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (57)
Ipilimumab
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P1/2CCC (55)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Abemaciclib
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP2CCC (53)
ag-120
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Anamorelin
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Bendamustine
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Dabrafenib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Showing 26 to 50 of 124 assets
PreviousPage 2 of 5Next